DOI QR코드

DOI QR Code

Diabetes Mellitus and Renal Cell Carcinoma - A Hospital Based Study from Kathmandu Valley

  • Gupta, Satrudhan Pd. (Nepalese Army Institute of Health Sciences) ;
  • Mittal, Ankush (Nepalese Army Institute of Health Sciences) ;
  • Jha, Dipendra Kumar (Nepalese Army Institute of Health Sciences) ;
  • Pandeya, Dipendra Raj (Nepalese Army Institute of Health Sciences) ;
  • Sathian, Brijesh (Department of Community Medicine, Manipal College of Medical Sciences)
  • Published : 2012.10.31

Abstract

Objective: To diagnose renal cell carcinoma at early stages and for better prognosis, the main objective of our current study was to understand any association with diabetes with relation to age, gender, history of disease, diabetic laboratory parameters, tumor size and grade. Materials and Methods: This hospital based study was carried out using data retrieved from the register maintained in the Department of Biochemistry of Nepalese Army Institute of Health Sciences between $1^{st}$ December, 2011 and $31^{st}$ May, 2012. The variables collected were age, gender, HbA1c, serum creatinine, fasting blood glucose. One way ANOVA was applied to examine statistical significance of differences between groups. The LSD post hoc test was used for the comparison of means of case groups. Results: Of the total 140 cases of renal cell carcinoma, 79 patients were also suffering from diabetes mellitus. The number of females (47) was more in diabetic RCC patients when compared to males (32). Significance was observed in levels of serum creatinine for tumor size >10cm ($0.0001^*$). The highest value of glycated hemoglobin (8.9%) and fasting blood sugar(148.3mg/dl)in cases of renal cell carcinoma along with diabetes mellitus was found in tumour size of 1-5cm. Conclusion: Diabetes mellitus has independent prognostic significance in RCC in relation to tumour size and grade.

Keywords

References

  1. Eckerbom S, Bergqvist Y, Jeppsson JO (1994). Improved method for analysis of glycated haemoglobin by ion exchange chromatography. Ann Clin Biochem, 31, 355-60. https://doi.org/10.1177/000456329403100409
  2. Habib SL, Prihoda TJ, Luna M, et al (2012). Diabetes and risk of renal cell carcinoma. J Cancer, 3, 42-8. https://doi.org/10.7150/jca.3718
  3. Klinghoffer Z, Yang B, Kapoor A, et al (2009). Obesity and renal cell carcinoma: epidemiology,underlying mechanisms and management considerations. Expert Rev Anticancer Ther, 9, 975-87. https://doi.org/10.1586/era.09.51
  4. Jemal A, Siegel R, Ward E, et al (2007). Cancer statistics, 2007. CA Cancer J Clin, 57, 43-66. https://doi.org/10.3322/canjclin.57.1.43
  5. Lindblad P, Chow WH, Chan J, et al (1999). The role of diabetes mellitus in the etiology of renal cell cancer. Diabetologia, 42, 107-12. https://doi.org/10.1007/s001250051122
  6. Luke C, Sargent N, Pittman K, et al (2011). Epidemiology of cancers of the kidney in an Australian population. Asian Pac J Cancer Prev, 12, 2893-99.
  7. Mori M, Saitoh S, Takagi S, et al (2000). A review of cohort studies on the association between history of diabetes mellitus and occurrence of cancer. Asian Pac J Cancer Prev, 1, 269-76.
  8. Peake M, Whiting M (2006). Measurement of serum creatinine - current status and future goals. Clin Biochem Rev, 27, 173-84.
  9. Singam P, Ho C, Hong GE (2010). Clinical characteristics of renal cancer in Malaysia : a ten year review. Asian Pac J Cancer Prev, 11, 503-6.
  10. Trinder P (1969). Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor. Ann Clin Biochem, 6, 24-7. https://doi.org/10.1177/000456326900600108

Cited by

  1. Diabetes - Increased Risk for Cancers through Chromosomal Aberrations? vol.15, pp.11, 2014, https://doi.org/10.7314/APJCP.2014.15.11.4571
  2. Diabetes Mellitus as a Risk Factor for High Grade Renal Cell Carcinoma vol.15, pp.9, 2014, https://doi.org/10.7314/APJCP.2014.15.9.3993
  3. Metformin and lung cancer risk of patients with type 2 diabetes mellitus: A meta-analysis vol.3, pp.2, 2015, https://doi.org/10.3892/br.2015.417
  4. Prevention of kidney cancer incidence and recurrence pp.0963-0643, 2018, https://doi.org/10.1097/MOU.0000000000000454